ClinicalTrials.Veeva

Menu

Cerebral Oxygenation in Cardiac Arrest and Hypothermia (CoCaHYp)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Completed

Conditions

Cardiac Arrest

Treatments

Device: near infrared spectroscopy (INVOS®, Covidien)

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01531426
CoCa-01-12

Details and patient eligibility

About

Data indicate that neurological prognostication is difficult after cardiac arrest if mild therapeutic hypothermia is part of the post resuscitation care. Cerebral oxygenation detected by near-infrared spectroscopy, could be a new, non-invasive index marker for outcome assessment after cardiac arrest. The investigators hypothesize that cardiac arrest survivors with a continuously low cerebral oxygenation index have a poor prognosis.

Full description

The measurement of cerebral oxygen saturation by a non-invasive near-infrared monitor, INVOS® (In-Vivo Optical Spectroscopy; Covidien) can detect changes in oxygen levels reflecting regional blood oxygen saturation of the brain tissue beneath the sensor. If this monitoring can add further information towards reliable prognostication after cardiac arrest is unknown so far.

Enrollment

94 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • over 18 years

Exclusion criteria

  • under 18 years

Trial design

94 participants in 1 patient group

NIRS continuous monitoring
Treatment:
Device: near infrared spectroscopy (INVOS®, Covidien)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems